Curanex Pharmaceuticals Inc Earnings Per Share (Basic)
Curanex Pharmaceuticals Inc (CURX) reported Earnings Per Share (Basic) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Curanex Pharmaceuticals Inc earnings per share, basic for the quarter ending 2026-06-30 was -$0.12.
- Curanex Pharmaceuticals Inc earnings per share, basic for the quarter ending 2026-03-31 was -$0.11.
- Curanex Pharmaceuticals Inc earnings per share, basic for the quarter ending 2025-12-31 was -$0.11.
- Curanex Pharmaceuticals Inc earnings per share, basic for the quarter ending 2025-09-30 was -$0.04.
- Curanex Pharmaceuticals Inc earnings per share, basic for fiscal 2025 was -$0.17.
- Curanex Pharmaceuticals Inc earnings per share, basic for fiscal 2024 was -$0.03.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.12 10-Q · filed 2026-08-14 | -$0.23 10-Q · filed 2026-08-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$0.11 10-Q · filed 2026-05-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.17 10-K · filed 2026-03-30 |
| 2025-09-30 | -$0.04 10-Q · filed 2025-11-17 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.05 10-Q · filed 2025-11-17 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | -$0.01 10-Q · filed 2026-08-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$0.01 10-Q · filed 2026-05-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2024-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.03 10-K · filed 2026-03-30 |
| 2024-09-30 | -$0.04 10-Q · filed 2025-11-17 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$0.05 10-Q · filed 2025-11-17 | |
| 2024-06-30 | -$0.02 10-Q · filed 2025-09-09 | -$0.05 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |